Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Research and Development Expense (Annual): 364.10M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 364.10M |
| December 31, 2022 | 224.25M |
| December 31, 2021 | 128.20M |
| December 31, 2020 | 43.41M |
| Date | Value |
|---|---|
| December 31, 2019 | 24.54M |
| December 31, 2018 | 11.54M |
| December 31, 2017 | 3.616M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
24.54M
Minimum
2019
364.10M
Maximum
2023
156.90M
Average
128.20M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Bristol-Myers Squibb Co | 9.299B |
| RayzeBio inc (DELISTED) | 61.18M |
| Icosavax Inc (DELISTED) | 65.41M |
| Madrigal Pharmaceuticals Inc | 272.35M |
| Theseus Pharmaceuticals Inc (DELISTED) | 35.70M |